Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-17T20:25:38.070Z.
Calculation as of: 2026-09-17T20:25:38.070Z.
Quote observation: 2026-09-17T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cb6c10048925737cd567d1e5bafd28a4c0b29ce3f2197cf2dd91206c373d3f67
PEG RATIO
N/A
Elevance Health Inc.
Market Cap
$89.84B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Elevance Health Inc. (ELV) | $89.84B | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $92.89B | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.33B | N/A |
| GSK plc (GSK)vs › | $102.30B | N/A |
| McKesson Corporation (MCK)vs › | $102.98B | N/A |
| Sanofi (SNY)vs › | $103.59B | N/A |
| Cigna Corporation (CI)vs › | $72.93B | N/A |
| Stryker Corporation (SYK)vs › | $107.39B | N/A |
| Boston Scientific Corporation (BSX)vs › | $64.73B | N/A |
| CVS Health Corp. (CVS)vs › | $115.18B | N/A |
PEG Ratio
N/A
P/E Ratio
18.4
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
